Abstract
2 alpha-Cyanoprogesterone potently inhibits the conversion of [3H]pregnenolone into progesterone catalysed by bovine corpora lutea, bovine adrenal cortex and human term placenta microsomes (microsomal fractions), yielding IC50 (concentration causing 50% inhibition) values of 66 nM, 120 nM and 700 nM respectively. By contrast, it is an exceedingly poor inhibitor of the isomerization of pregn-5-ene-3,20-dione, yielding IC50 values between 50 and 70 microM. On this basis, 2 alpha-cyanoprogesterone would appear to be an extraordinarily selective inhibitor of the 3 beta-hydroxysteroid dehydrogenase. Dixon plots indicate that it is a very-tight-binding competitive inhibitor of the corpus-luteum enzyme, yielding a Ki of 15 nM. In the bovine adrenal cortex and human placenta the steroid is less potent and inhibits the dehydrogenase non-competitively with Ki values of 150 nM and 1.0 microM respectively. Thus 2 alpha-cyanoprogesterone inhibits the corpus-luteum dehydrogenase with substantial selectivity. Because of its high affinity for the ovarian enzyme, the presence of low-micromolar concentrations of 2 alpha-cyanoprogesterone can promote a complete cessation of progesterone synthesis in corpora-lutea microsomes for several hours. Since this effect is observed in the presence of saturating concentrations of pregnenolone (50 microM), it is predicted that this inhibitor may be even more potent in vivo. 2 alpha-Cyanoprogesterone displays very low affinity for the human progesterone receptor, yielding a Kd of 600 nM as against a Kd of 1.6 nM for progesterone. It is suggested that 2 alpha-cyanoprogesterone may be a selective inhibitor of ovarian progesterone synthesis and may act as an effective anti-gestational agent in vivo.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Csapo A. I., Resch B. A. Induction of preterm labor in the rat by antiprogesterone. Am J Obstet Gynecol. 1979 Aug 1;134(7):823–827. doi: 10.1016/0002-9378(79)90954-2. [DOI] [PubMed] [Google Scholar]
- Csapo A. I., Resch B., Csapo E. F., Salau G. Effects of antiprogesterone on pregnancy. I. Midpregnancy. Am J Obstet Gynecol. 1979 Jan 15;133(2):176–183. doi: 10.1016/0002-9378(79)90472-1. [DOI] [PubMed] [Google Scholar]
- Csapo A. I., Resch B. Prevention of implantation by antiprogesterone. J Steroid Biochem. 1979 Jul;11(1C):963–969. doi: 10.1016/0022-4731(79)90039-6. [DOI] [PubMed] [Google Scholar]
- Goldman A. S. Further studies of steoidal inhibitors of delpha5, 3beta-hydroxysteroid dehydrogenase and delta5-delta4, 3-ketosteroid isomerase in Pseudomonas testosteroni and in bovine adrenals. J Clin Endocrinol Metab. 1968 Nov;28(11):1539–1546. doi: 10.1210/jcem-28-11-1539. [DOI] [PubMed] [Google Scholar]
- Goldman A. S., Yakovac W. C., Bongiovanni A. M. Persistent effects of a synthetic androstene derivative on activities of 3-beta-hydroxysteroid dehydrogenase and glucose-6-phosphate dehydrogenase in rats. Endocrinology. 1965 Dec;77(6):1105–1118. doi: 10.1210/endo-77-6-1105. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Penning T. M. Irreversible inhibition of delta 5-3-oxosteroid isomerase by 2-substituted progesterones. Biochem J. 1985 Mar 1;226(2):469–476. doi: 10.1042/bj2260469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WILKINSON G. N. Statistical estimations in enzyme kinetics. Biochem J. 1961 Aug;80:324–332. doi: 10.1042/bj0800324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Hertogh R., van der Heyden I., Ekka E. "Unbound" ligand adsorption on dextran-coated charcoal: practical considerations. J Steroid Biochem. 1975 Sep;6(9):1333–1337. doi: 10.1016/0022-4731(75)90362-3. [DOI] [PubMed] [Google Scholar]
